E. Heerdink
发表
D. van Dijk,
T. Egberts,
A. Slooter,
2020,
Journal of critical care.
A. de Boer,
E. Heerdink,
O. Klungel,
2005,
Journal of hypertension.
A. de Boer,
E. Heerdink,
O. Klungel,
2005,
The Annals of pharmacotherapy.
T. Egberts,
E. Heerdink,
B. V. D. van den Bemt,
2021
.
E. Heerdink,
A. Hazekamp,
2013,
European Journal of Clinical Pharmacology.
T. Egberts,
D. G. Janssen,
E. Heerdink,
2017,
Military medicine.
H. Leufkens,
E. Heerdink,
C. Lamers,
2002,
Pharmacoepidemiology and drug safety.
R. Kupka,
L. Stoker,
E. Heerdink,
2018,
International Journal of Bipolar Disorders.
E. Heerdink,
H. Leufkens,
A. Bakker,
1995,
Pharmacy World and Science.
H. Leufkens,
E. Heerdink,
P. Stolk,
2006,
Journal of Human Hypertension.
A. Egberts,
E. Heerdink,
K. Movig,
2005,
European Journal of Clinical Pharmacology.
J. J. Stolker,
W. Nolen,
H. Leufkens,
2003,
European Journal of Clinical Pharmacology.
T. Egberts,
E. Heerdink,
E. de Jong,
2018,
Journal of clinical psychopharmacology.
H. Gardarsdottir,
T. Egberts,
E. Heerdink,
2010,
The Annals of pharmacotherapy.
H. Leufkens,
E. Heerdink,
C. Lamers,
1997,
Alimentary pharmacology & therapeutics.
M. Bouvy,
E. Heerdink,
H. Geers,
2011,
Archives of internal medicine.
A. de Boer,
E. Heerdink,
O. Klungel,
2006,
Journal of clinical epidemiology.
R. Herings,
J. Meer,
E. Heerdink,
2005,
European Journal of Clinical Microbiology and Infectious Diseases.
A. Hoes,
H. Leufkens,
M. Bouvy,
2002,
Pharmacoepidemiology and drug safety.
H. Gardarsdottir,
T. Egberts,
E. Heerdink,
2010,
Journal of clinical epidemiology.
P. Groenewegen,
H. Leufkens,
E. Heerdink,
2007,
The Annals of pharmacotherapy.
A. de Boer,
E. Heerdink,
O. Klungel,
2004,
Journal of hypertension.
H. Gardarsdottir,
T. Egberts,
L. van Dijk,
2010,
Journal of affective disorders.
T. Egberts,
P. Jansen,
E. Heerdink,
2010,
Journal of clinical psychopharmacology.
M. Bouvy,
E. Heerdink,
H. Geers,
2011,
The Annals of pharmacotherapy.
M. Bouvy,
E. Heerdink,
L. Schoonhoven,
2022,
Journal of Interprofessional Education & Practice.
D. Grobbee,
H. Leufkens,
R. Stolk,
2003,
Pharmacoepidemiology and drug safety.
T. Egberts,
L. Stoker,
E. Heerdink,
2015,
Journal of psychopharmacology.
M. Bouvy,
E. Heerdink,
O. Klungel,
1999,
The British journal of general practice : the journal of the Royal College of General Practitioners.
E. Heerdink,
O. Klungel,
A. Boer,
2004,
The Lancet.
J. J. Stolker,
T. Egberts,
E. Heerdink,
2016,
Research in developmental disabilities.
Willemijn M. Meijer,
H. Engeland,
T. Egberts,
2014,
European Child & Adolescent Psychiatry.
T. Egberts,
D. G. Janssen,
E. Heerdink,
2020,
European Neuropsychopharmacology.
M. Bouvy,
E. Heerdink,
K. Hersberger,
2016,
The Annals of pharmacotherapy.
E. Heerdink,
J. Hugtenburg,
I. Witte,
2006,
Acta paediatrica.
J. J. Stolker,
T. Egberts,
E. Heerdink,
2016,
Journal of clinical psychopharmacology.
H. Leufkens,
E. Heerdink,
S. Belitser,
2008,
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
J. Ottervanger,
B. Stricker,
R. Herings,
1998,
Archives of internal medicine.
H. van Engeland,
T. Egberts,
E. Heerdink,
2010,
Attention deficit and hyperactivity disorders.
G. H. de Weert-van Oene,
E. Heerdink,
F. Termorshuizen,
2017,
Drug and alcohol dependence.
T. Egberts,
L. Stoker,
E. Heerdink,
2019,
BMJ Open.
M. Bouvy,
E. Heerdink,
E. Koster,
2014,
European Journal of Pediatrics.
H. Engeland,
T. Egberts,
E. Heerdink,
2015,
Social Psychiatry and Psychiatric Epidemiology.
J. J. Stolker,
T. Egberts,
E. Heerdink,
2013,
Research in developmental disabilities.
Changes in the defined daily dose; CYP2D6/CYP3A metabolism as an indicator for dose-setting problems
H. Leufkens,
E. Heerdink,
P. Stolk,
2005,
European Journal of Clinical Pharmacology.
T. Egberts,
D. Cohen,
E. Heerdink,
2010,
Journal of clinical psychopharmacology.
A. Hoes,
J. Urquhart,
D. Grobbee,
2003,
Journal of cardiac failure.
A. Egberts,
H. Leufkens,
E. Heerdink,
2002,
Nederlands tijdschrift voor geneeskunde.
A. Egberts,
M. Bouvy,
C. J. Blaey,
2006,
The Annals of pharmacotherapy.
A. Volkers,
L. van Dijk,
E. Heerdink,
2007,
Pharmacoepidemiology and drug safety.
H. Leufkens,
L. van Dijk,
E. Heerdink,
2005,
Pharmacoepidemiology and drug safety.
T. Egberts,
E. Heerdink,
A. Risselada,
2014,
Journal of clinical psychopharmacology.
T. Egberts,
E. Heerdink,
A. Risselada,
2012,
Journal of clinical psychopharmacology.
M. Baulac,
M. Walker,
S. Shorvon,
2008,
Epilepsia.
P. Spreeuwenberg,
L. van Dijk,
D. D. de Bakker,
2022
.
W. Cahn,
E. Heerdink,
A. Huisman,
2013,
European Neuropsychopharmacology.
T. Egberts,
E. Heerdink,
E. van den Ban,
2022,
BMJ Open.
H. Leufkens,
E. Heerdink,
P. Stolk,
2009,
Orphanet journal of rare diseases.
John Urquhart,
J. Urquhart,
H. Leufkens,
2002,
Pharmacoepidemiology and drug safety.
W. Nolen,
H. Leufkens,
E. Heerdink,
2005
.
G. T. Werf,
J. Urquhart,
A. Egberts,
1994,
Pharmacy World & Science.
A. Slooter,
E. Heerdink,
W. Knol,
2018,
Critical care medicine.
T. Egberts,
A. Slooter,
E. Heerdink,
2018,
PloS one.
R. Kupka,
E. Heerdink,
M. Nederlof,
2018,
Bipolar disorders.
Factors associated with non-response in proton pump inhibitor users: a study of lansoprazole therapy
H. Leufkens,
E. Heerdink,
C. Lamers,
2001,
Pharmacy World and Science.
T. Egberts,
E. Heerdink,
H. van Megen,
2011,
Pharmacogenomics.
E. Heerdink,
J. Hugtenburg,
Yung Hwo Tso,
2005,
Acta paediatrica.
J. J. Stolker,
T. Egberts,
E. Heerdink,
2006
.
D. Grobbee,
B. Stricker,
E. Heerdink,
2002,
Archives of internal medicine.
K. Taxis,
A. Egberts,
H. Gardarsdottir,
2016,
Journal of clinical psychopharmacology.
A. Egberts,
M. Bouvy,
E. Heerdink,
2008,
The Annals of pharmacotherapy.
A. Hoes,
H. Leufkens,
M. Bouvy,
2003,
Heart.
R. Herings,
M. Bouvy,
E. Heerdink,
2001,
Pharmacy World and Science.
A. Hoes,
H. Leufkens,
M. Bouvy,
2003,
European journal of heart failure.
D. Grobbee,
E. Heerdink,
O. Klungel,
2012,
Molecular Diagnosis & Therapy.
A. Egberts,
E. Heerdink,
J. Hugtenburg,
2005,
Pharmacy World and Science.
C. Correll,
W. Staal,
E. Heerdink,
2012,
Journal of child and adolescent psychopharmacology.
E. Heerdink,
H. van Megen,
J. van der Weide,
2010,
Psychiatric genetics.
T. Egberts,
E. Heerdink,
A. Risselada,
2011,
Pharmacogenomics.
M. Bouvy,
L. van Dijk,
E. Heerdink,
2015,
Patient education and counseling.
E. Heerdink,
D. Philbert,
M. Bouvy,
2015,
International journal of clinical practice.
M. Bouvy,
L. van Dijk,
E. Heerdink,
2014,
BMC Health Services Research.
T. Egberts,
Anna Grube,
E. Heerdink,
2010,
Journal of clinical psychopharmacology.
D. Klein,
S. Rapoport,
E. Heerdink,
2010,
Prostaglandins, leukotrienes, and essential fatty acids.
J. J. Stolker,
H. Gardarsdottir,
T. Egberts,
2009,
American journal of epidemiology.
M. Bouvy,
L. van Dijk,
E. Heerdink,
2016,
Front. Pharmacol..
A. Hoes,
R. Herings,
H. Leufkens,
2000,
Archives of internal medicine.
E. Heerdink,
H. Hout,
O. Brook,
2003,
European Neuropsychopharmacology.
P. Groenewegen,
H. Leufkens,
L. van Dijk,
2009,
BMC health services research.
T. Egberts,
E. Heerdink,
E. van den Ban,
2021,
Frontiers in Psychiatry.
Anthonius de Boer,
E. Heerdink,
O. Klungel,
2006,
The Annals of pharmacotherapy.
H. Leufkens,
E. Heerdink,
C. Lamers,
2002,
Drug safety.
A. Hoes,
H. Leufkens,
M. Bouvy,
2003,
Drug safety.
P. Groenewegen,
L. van Dijk,
D. D. de Bakker,
2007,
BMC Health Services Research.
A. Egberts,
E. Heerdink,
J. Weide,
2013,
European Journal of Clinical Pharmacology.
J. J. Stolker,
H. Gardarsdottir,
T. Egberts,
2009,
Journal of clinical psychopharmacology.
E. Heerdink,
A. Hazekamp,
Bas de Hoop,
2018,
Cannabis and cannabinoid research.
J. J. Stolker,
T. Egberts,
E. Heerdink,
2006,
The Journal of clinical psychiatry.
T. Egberts,
L. Stoker,
E. Heerdink,
2017,
BMC Psychiatry.
A. Egberts,
E. Heerdink,
E. V. van Geffen,
2011,
Research in social & administrative pharmacy : RSAP.
H. Gardarsdottir,
T. Egberts,
L. Stoker,
2018,
Therapeutic advances in psychopharmacology.
H. Gardarsdottir,
T. Egberts,
L. Stoker,
2015,
The Annals of pharmacotherapy.
H. Gardarsdottir,
T. Egberts,
L. Stoker,
2014,
The Annals of pharmacotherapy.
Risk of acute coronary syndrome in elderly users of antipsychotic drugs: a nested case-control study
T. Egberts,
P. Jansen,
E. Heerdink,
2012,
Heart.
T. Egberts,
D. G. Janssen,
E. Heerdink,
2019,
Military medicine.
Peter P. Groenewegen,
Stefan R. Florentinus,
Patrick C. Souverein,
2006,
BMC Medical Informatics Decis. Mak..
Eibert R. Heerdink,
Olaf H. Klungel,
Anthonius Boer,
2006,
American journal of cardiovascular drugs : drugs, devices, and other interventions.
Sandra van Dulmen,
S. van Dulmen,
D. D. de Ridder,
2007,
BMC Health Services Research.
H. Leufkens,
E. Heerdink,
E. Heerdink,
1999,
Pharmacoepidemiology and drug safety.
H. Leufkens,
E. Heerdink,
J. V. van Eijk,
2002,
Pharmacoepidemiology and Drug Safety.
T. Egberts,
E. Heerdink,
M. Majoie,
2008,
Epilepsia.
P. Groenewegen,
H. Leufkens,
E. Heerdink,
2006,
The Annals of pharmacotherapy.
H. Gardarsdottir,
E. Heerdink,
T. Egberts,
2021,
Therapeutic advances in psychopharmacology.
E. Heerdink,
C. A. de Vries Feyens,
M. Nederlof,
2017,
BMJ Case Reports.
E. Heerdink,
O. Klungel,
R. Groenwold,
2022,
JAMA psychiatry.
J. Urquhart,
H. Leufkens,
M. Bouvy,
2001,
British Journal of Psychiatry.
A. de Boer,
E. Heerdink,
O. Klungel,
2006,
Pharmacoepidemiology and drug safety.
M. Bouvy,
E. Heerdink,
B. V. van Wijk,
2013,
Front. Pharmacol..
J. Avorn,
D. Solomon,
A. de Boer,
2007,
Journal of hypertension.
M. Bouvy,
E. Heerdink,
E. Koster,
2015,
Journal of child and adolescent psychopharmacology.
M. Bouvy,
E. Heerdink,
P. Spreeuwenberg,
2013,
European Journal of Clinical Pharmacology.
E. Heerdink,
H. Leufkens,
A. Claessens,
2000
.
S. Dulmen,
E. Heerdink,
N. Kleefstra,
2019
.
S. Dulmen,
E. Heerdink,
N. Kleefstra,
2019
.
S. Dulmen,
E. Heerdink,
N. Kleefstra,
2019
.
J. J. Stolker,
F. Zitman,
E. Heerdink,
2004,
Pharmacoepidemiology and drug safety.
T. Egberts,
E. Heerdink,
E. de Jong,
2019,
Journal of child and adolescent psychopharmacology.
D. Grobbee,
B. Stricker,
E. Heerdink,
2002,
Archives of internal medicine.
Willemijn M. Meijer,
H. Engeland,
T. Egberts,
2014,
European Child & Adolescent Psychiatry.
T. Egberts,
L. Stoker,
E. Heerdink,
2015,
Journal of psychopharmacology.
E. Heerdink,
V. Deneer,
M. Tjoeng,
2013,
European Journal of Clinical Pharmacology.
H. Leufkens,
E. Heerdink,
A. Bakker,
1999,
Pharmacoepidemiology and drug safety.
H. Gardarsdottir,
T. Egberts,
L. van Dijk,
2010,
Journal of affective disorders.
J. J. Stolker,
T. Egberts,
E. Heerdink,
2006,
The Journal of clinical psychiatry.
H. Leufkens,
E. Heerdink,
J. V. van Eijk,
2001,
British journal of clinical pharmacology.
A. Beekman,
T. Egberts,
E. Heerdink,
2018,
Journal of clinical psychopharmacology.
E. Heerdink,
H. Hout,
O. Brook,
2002
.
M. Bouvy,
L. van Dijk,
E. Heerdink,
2023,
BMC Health Services Research.
S. Schneeweiss,
E. Heerdink,
H. Leufkens,
2008,
Contraception.
E. Heerdink,
H. van Megen,
J. van der Weide,
2010,
Psychiatric genetics.